Followers | 1 |
Posts | 401 |
Boards Moderated | 0 |
Alias Born | 01/02/2010 |
Friday, January 08, 2010 10:10:44 AM
Recent INDP News
- Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference • GlobeNewswire Inc. • 03/28/2024 12:00:00 PM
- Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 03/25/2024 12:30:00 PM
- Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024 • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/13/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 04:01:33 PM
- Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort • GlobeNewswire Inc. • 03/04/2024 12:30:00 PM
- Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels • GlobeNewswire Inc. • 02/08/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 09:15:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 09:05:34 PM
- European Patent Office Approves Key Patent for Indaptus Therapeutics’ Platform Technology • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 09:06:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:05:38 PM
- Indaptus Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/06/2023 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 01:13:21 PM
- Indaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune Response of More than Fifty Cytokines and Chemokines in Patients Following a Single Dose in First Cohort of Ongoing Phase 1 Study • GlobeNewswire Inc. • 11/06/2023 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 01:12:31 PM
- Indaptus Therapeutics to Present Positive Pharmacodynamic (PD) Immune and Pharmacokinetic (PK) Results with Patients from First Cohort of Ongoing Phase 1 Study of Decoy20 at Cancer Immunotherapy Meeting • GlobeNewswire Inc. • 10/31/2023 01:01:00 PM
- Indaptus Therapeutics to Present at the LD Micro Main Event XVI • GlobeNewswire Inc. • 09/27/2023 12:00:00 PM
- Registration Is Now Open For Tribe Public’s Webinar Event "Immunotherapy Reimagined" Featuring Indaptus Therapeutics’ CEO On Friday, September 29, 2023 • GlobeNewswire Inc. • 09/26/2023 12:00:00 PM
- Indaptus Therapeutics Doses First Patient in Second Cohort of Single Dose Ranging Study of Decoy20 • GlobeNewswire Inc. • 09/19/2023 12:00:00 PM
- Indaptus Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/06/2023 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 10:01:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 12:15:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:10:37 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM